SC
ACB

Swan Capital’s Aurora Cannabis ACB Stock Holding History

Swan Capital’s Portfolio ACB Stock Details ACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-37
Closed -$157 – 493
2025
Q2 		$157 Buy
+37
New +$179 ﹤0.01% 452

Other funds holding ACB

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Swan Capital's ACB Position: Q3 2025 in Review

Swan Capital sold out of Aurora Cannabis (ACB) in Q3 2025, closing a stake of 37 shares — an estimated $157 sold.

Swan Capital first reported a position in ACB in Q2 2025 and held it in 1 quarter. The position peaked at $157 in Q2 2025. 164 funds tracked by Wall St. Rank hold ACB as of Q3 2025.

  • Swan Capital reported no remaining Aurora Cannabis position as of Q3 2025 after selling out during the quarter.
  • Swan Capital sold 37 Aurora Cannabis shares in Q3 2025, an estimated $157.
  • Swan Capital first reported a position in Aurora Cannabis in Q2 2025 and held it in 1 quarter.
  • Swan Capital's Aurora Cannabis position peaked at $157 in Q2 2025.
  • 164 funds tracked by Wall St. Rank held Aurora Cannabis as of Q3 2025.

Based on Swan Capital's 13F filing for Q3 2025, filed 14 Nov 2025.